Carol Young

1.0k total citations
29 papers, 779 citations indexed

About

Carol Young is a scholar working on Infectious Diseases, Epidemiology and Clinical Biochemistry. According to data from OpenAlex, Carol Young has authored 29 papers receiving a total of 779 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 8 papers in Epidemiology and 7 papers in Clinical Biochemistry. Recurrent topics in Carol Young's work include Bacterial Identification and Susceptibility Testing (7 papers), Antimicrobial Resistance in Staphylococcus (6 papers) and Viral gastroenteritis research and epidemiology (4 papers). Carol Young is often cited by papers focused on Bacterial Identification and Susceptibility Testing (7 papers), Antimicrobial Resistance in Staphylococcus (6 papers) and Viral gastroenteritis research and epidemiology (4 papers). Carol Young collaborates with scholars based in United States, United Kingdom and Spain. Carol Young's co-authors include John H. Vaughan, Robert I. Fox, T. C. Adamson, Duane W. Newton, Thomas Lehner, Nebojša Janjić, Urs A. Ochsner, Ian A. Critchley, Susan P. Ashdown and Paul Bourbeau and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Journal of Clinical Microbiology.

In The Last Decade

Carol Young

28 papers receiving 743 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carol Young United States 17 220 193 124 117 102 29 779
Joyce E. P. Vrijenhoek Netherlands 12 150 0.7× 111 0.6× 58 0.5× 80 0.7× 160 1.6× 20 643
Adam B. Raff United States 15 250 1.1× 314 1.6× 144 1.2× 271 2.3× 209 2.0× 29 1.1k
Mario Delia Italy 16 180 0.8× 246 1.3× 36 0.3× 102 0.9× 78 0.8× 48 824
Jehoon Lee South Korea 16 126 0.6× 149 0.8× 31 0.3× 130 1.1× 151 1.5× 53 768
Govindarajan Rajagopalan United States 19 307 1.4× 129 0.7× 45 0.4× 463 4.0× 286 2.8× 53 1.0k
Jānis Gardovskis Latvia 16 253 1.1× 140 0.7× 155 1.3× 45 0.4× 215 2.1× 93 1.1k
Chiara Cattaneo Italy 25 387 1.8× 553 2.9× 281 2.3× 221 1.9× 198 1.9× 102 2.2k
S. Špánik Slovakia 20 382 1.7× 337 1.7× 151 1.2× 87 0.7× 266 2.6× 79 1.4k
Noam Benyamini Israel 17 289 1.3× 144 0.7× 26 0.2× 140 1.2× 99 1.0× 53 963
H. Benchikhi Morocco 14 168 0.8× 195 1.0× 68 0.5× 75 0.6× 54 0.5× 87 821

Countries citing papers authored by Carol Young

Since Specialization
Citations

This map shows the geographic impact of Carol Young's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol Young with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol Young more than expected).

Fields of papers citing papers by Carol Young

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carol Young. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol Young. The network helps show where Carol Young may publish in the future.

Co-authorship network of co-authors of Carol Young

This figure shows the co-authorship network connecting the top 25 collaborators of Carol Young. A scholar is included among the top collaborators of Carol Young based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carol Young. Carol Young is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wigginton, Krista R., Peter J. Arts, Herek L. Clack, et al.. (2020). Validation of N95 Filtering Facepiece Respirator Decontamination Methods Available at a Large University Hospital. Open Forum Infectious Diseases. 8(2). ofaa610–ofaa610. 29 indexed citations
2.
Patel, Twisha S, Keith S. Kaye, John Mills, et al.. (2019). 522. In Vitro Antimicrobial Activity of Ceftazidime/Avibactam Compared with Ceftolozane/Tazobactam Against Real-world Clinical Isolates of Pseudomonas aeruginosa at a Large Academic Tertiary Care Hospital. Open Forum Infectious Diseases. 6(Supplement_2). S251–S252. 1 indexed citations
3.
Patel, Twisha S, Keith S. Kaye, John Mills, et al.. (2019). 521. Comparative In Vitro Activity of Meropenem/Vaborbactam and Meropenem Against a Collection of Real-World Clinical Isolates of Pseudomonas aeruginosa. Open Forum Infectious Diseases. 6(Supplement_2). S251–S251. 5 indexed citations
4.
5.
Tan, Bei, Jyh‐Chin Yang, Carol Young, et al.. (2017). Helicobacter pylori Antimicrobial Susceptibility Testing-Guided Salvage Therapy in the USA: A Real Life Experience. Digestive Diseases and Sciences. 63(2). 437–445. 20 indexed citations
6.
Young, Carol, et al.. (2017). Bacterial Contamination of CT Equipment. Academic Radiology. 24(8). 923–929. 7 indexed citations
7.
Young, Carol, et al.. (2017). In Vitro Activity of Ceftolozane-Tazobactam and Other Antimicrobial Agents against Burkholderia cepacia Complex and Burkholderia gladioli. Antimicrobial Agents and Chemotherapy. 61(9). 19 indexed citations
8.
Hernandez, Diana R., Duane W. Newton, Nathan A. Ledeboer, et al.. (2015). Multicenter Evaluation of MRSASelectII Chromogenic Agar for Identification of Methicillin-Resistant Staphylococcus aureus from Wound and Nasal Specimens. Journal of Clinical Microbiology. 54(2). 305–311. 9 indexed citations
9.
Anderson, Neil W., Blake W. Buchan, Carol Young, et al.. (2013). Multicenter Clinical Evaluation of VRESelect Agar for Identification of Vancomycin-Resistant Enterococcus faecalis and Enterococcus faecium. Journal of Clinical Microbiology. 51(8). 2758–2760. 12 indexed citations
10.
11.
12.
Critchley, Ian A., Carol Young, James M. Bullard, et al.. (2009). Spectrum of activity and mode of action of REP3123, a new antibiotic to treat Clostridium difficile infections. Journal of Antimicrobial Chemotherapy. 63(5). 954–963. 62 indexed citations
13.
Ochsner, Urs A., S.J. Bell, Timothy N. Hoang, et al.. (2009). Inhibitory effect of REP3123 on toxin and spore formation in Clostridium difficile, and in vivo efficacy in a hamster gastrointestinal infection model. Journal of Antimicrobial Chemotherapy. 63(5). 964–971. 65 indexed citations
14.
Bischof, Larry J., et al.. (2009). Comparison of Chromogenic Media to BD GeneOhm Methicillin-Resistant Staphylococcus aureus (MRSA) PCR for Detection of MRSA in Nasal Swabs. Journal of Clinical Microbiology. 47(7). 2281–2283. 33 indexed citations
15.
Vaena, Daniel A., Paul Walker, Kenneth Pennington, et al.. (2003). Phase II study of low-dose topotecan in myelodysplastic syndromes: a Hoosier Oncology Group (HOG) study. Leukemia Research. 28(1). 49–52. 4 indexed citations
16.
Young, Carol & Thomas Lehner. (1988). A comparative investigation of three methods of separation of CD4 and CD8 cells from human peripheral blood cells. Journal of Immunological Methods. 107(1). 31–40. 8 indexed citations
17.
Young, Carol, Thomas Lehner, & C. G. Barnes. (1988). CD4 and CD8 cell responses to herpes simplex virus in Behçet's disease.. PubMed. 73(1). 6–10. 33 indexed citations
18.
Young, Carol, Lester E. Wold, R A McLeod, & F H Sim. (1988). Primary Leiomyosarcoma of Bone. Orthopedics. 11(4). 615–618. 17 indexed citations
19.
Young, Carol, T. C. Adamson, John H. Vaughan, & Robert I. Fox. (1984). Immunohistologic characterization of synovial membrane lymphocytes in rheumatoid arthritis. Arthritis & Rheumatism. 27(1). 32–39. 160 indexed citations
20.
Young, Carol. (1981). The New Penguin Dictionary of Electronics. Leonardo. 14(3). 259–259.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joyce E. P. Vrijenhoek Breakdown of academic impact, for papers by Adam B. Raff Breakdown of academic impact, for papers by Mario Delia Breakdown of academic impact, for papers by Jehoon Lee Breakdown of academic impact, for papers by Govindarajan Rajagopalan Breakdown of academic impact, for papers by Jānis Gardovskis Breakdown of academic impact, for papers by Chiara Cattaneo Breakdown of academic impact, for papers by S. Špánik Breakdown of academic impact, for papers by Noam Benyamini Breakdown of academic impact, for papers by H. Benchikhi
Rankless by CCL
2026